Group Leader Positions


Paris Institute of Translational Neurosciences


Paris, France


Full applications must be sent by 15 November 2013 to The applications will be reviewed by the International Scientific Advisory Board of the institute. Short-listed applicants will be invited for an interview and oral presentation in Paris in late January 2014.

First Selections Announcement: 15 September 2013.

Finalists Oral Presentation: End of January 2014.


The Brain and Spine Institute (ICM) with the Institut Hospitalo Universitaire (IHU: Paris Institute of Translational Neurosciences) brings together more than 450 researchers, 300 physicians, and 900 nursing and paramedical staff, as well as a large network of public and industrial partners. It is dedicated to basic, translational, and clinical research in neuroscience as well as to the improvement of the quality of care and education. The ICM comprises 23 selected research teams, innovative technological platforms—molecular and cellular research, animal facilities, neuroimaging—an in-house neuroscience clinical research center, and has a floor reserved for spin-offs and companies. The ICM is located within the Pitié-Salpêtrière hospital, whose cohorts of neurological patients are the largest in France, thus offering a unique opportunity for translational research. Additionally, 13 National Reference Centers for rare diseases are also located at the Pitié-Salpêtrière, alongside the largest number of separate, rare neurological disease units in the country.

The ICM was one of the six candidates selected to be financed by the French investment for the future program and was granted University Hospital Institute (IHU) status. It brings together teams of researchers and physicians, of all origins, to promote excellence in research, training, patient care, and technology transfer in the field of the nervous system diseases.

Successful candidates will have the benefit of lab spaces in the institutes, state-of-the-art platforms, and core facilities. A stimulating international environment and graduate programs from the Université Pierre et Marie Curie (UPMC) are well established. A start-up package will be provided to the appointed group leaders. Assistance for applications to national and European programs will be provided (CNRS, Inserm, ANR, ATIP-Avenir, Equipes FRM, ERC) for their long-term insertion in France.


The institute is welcoming applications for group leader positions and wishes to reinforce three research axes:

  • Neurodegenerative disorders with a focus on cellular biology
  • Neuroimmunology
  • Modeling of behavior and diseases

However, it also strongly encourages applicants with open proposals in the field of neuroscience.

The candidates should be dynamic investigators with a strong track record. Applications from both junior investigators (to start a new group) and senior investigators (to move with a pre-existing group) will be considered. New groups are expected to start as soon as 2014.

Expressions of interest will include a short CV, a short list of publications, a brief description of past achievements and future research (two pages). The EoI must be sent by 15 July 2013 to

Short-listed applicants will be requested to send the full application proposal including:

  • Title, summary and five main publications (limited to two pages)
  • CV (limited to two pages)
  • Description of the research project (no more than 10 pages)
  • List of publications and conferences
  • Names and contacts of three referees